Aurobindo arm terminates pentavalent vaccine licence pact with Hilleman Labs
Aurobindo Pharma subsidiary Auro Vaccines has terminated a pentavalent vaccine candidate licence agreement with Hilleman Laboratories Singapore. The September 2023 agreement envisaged developing, manufacturing and commercialising a pentavalent vaccine candidate…